Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20130246Phase 3Completed
A Phase 3 trial of somatropin in growth hormone deficiency (GHD), sponsored by Shanghai United Cell Biotechnology Co., Ltd.. Started May 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20130246.